908 DEVICES INC. Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
908 DEVICES INC. (MASS) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of -$732.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2026-08-11
- 908 DEVICES INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-06-30 was -$732.00K.
- 908 DEVICES INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-03-31 was -$52.00K.
- 908 DEVICES INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-12-31 was $11.00K.
- 908 DEVICES INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-09-30 was $59.00K, a 91.69% decline year-over-year.
- 908 DEVICES INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2025 was -$1.09M.
- 908 DEVICES INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2024 was -$219.00K, a 138.62% decline from fiscal 2023.
- 908 DEVICES INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2023 was $567.00K, a 28.95% decline from fiscal 2022.
- 908 DEVICES INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2022 was $798.00K.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$732.00K 10-Q · filed 2026-08-11 | -$784.00K 10-Q · filed 2026-08-11 | -$773.00K derived: sum of 3 quarters · filed 2026-08-11 | -$714.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | -$52.00K 10-Q · filed 2026-05-06 | -$41.00K derived: sum of 2 quarters · filed 2026-05-06 | $18.00K derived: sum of 3 quarters · filed 2026-05-06 | $4.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $70.00K derived: sum of 2 quarters · filed 2026-03-09 | $56.00K derived: sum of 3 quarters · filed 2026-08-11 | -$1.09M 10-K · filed 2026-03-09 |
| 2025-09-30 | $59.00K 10-Q · filed 2025-11-10 | $45.00K derived: sum of 2 quarters · filed 2026-08-11 | -$1.10M 10-Q · filed 2025-11-10 | -$1.52M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | -$14.00K 10-Q · filed 2026-08-11 | -$1.16M 10-Q · filed 2026-08-11 | -$1.58M derived: sum of 3 quarters · filed 2026-08-11 | -$874.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | -$1.15M 10-Q · filed 2026-05-06 | -$1.57M derived: sum of 2 quarters · filed 2026-05-06 | -$860.00K derived: sum of 3 quarters · filed 2026-05-06 | -$982.00K derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | -$422.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $288.00K derived: sum of 2 quarters · filed 2026-03-09 | $166.00K derived: sum of 3 quarters · filed 2026-03-09 | -$219.00K 10-K · filed 2026-03-09 |
| 2024-09-30 | $710.00K 10-Q · filed 2025-11-10 | $588.00K derived: sum of 2 quarters · filed 2025-11-10 | $203.00K 10-Q · filed 2025-11-10 | $580.00K derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | -$122.00K 10-Q · filed 2025-08-05 | -$507.00K 10-Q · filed 2025-08-05 | -$130.00K derived: sum of 3 quarters · filed 2025-08-05 | -$286.00K derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | -$385.00K 10-Q · filed 2025-05-13 | -$8.00K derived: sum of 2 quarters · filed 2025-05-13 | -$164.00K derived: sum of 3 quarters · filed 2025-05-13 | -$109.00K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $377.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $221.00K derived: sum of 2 quarters · filed 2025-03-07 | $276.00K derived: sum of 3 quarters · filed 2025-03-07 | $567.00K 10-K · filed 2025-03-07 |
| 2023-09-30 | -$156.00K 10-Q · filed 2024-11-12 | -$101.00K derived: sum of 2 quarters · filed 2024-11-12 | $190.00K 10-Q · filed 2024-11-12 | $1.60M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $55.00K 10-Q · filed 2024-08-06 | $346.00K 10-Q · filed 2024-08-06 | $1.76M derived: sum of 3 quarters · filed 2024-08-06 | $1.14M derived: sum of 4 quarters · filed 2024-08-06 |
| 2023-03-31 | $291.00K 10-Q · filed 2024-05-03 | $1.70M derived: sum of 2 quarters · filed 2024-05-03 | $1.09M derived: sum of 3 quarters · filed 2024-05-03 | |
| 2022-12-31 | $1.41M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | $798.00K derived: sum of 2 quarters · filed 2024-03-08 | $798.00K 10-K · filed 2024-03-08 | |
| 2022-09-30 | -$613.00K 10-Q · filed 2023-11-07 | -$613.00K 10-Q · filed 2023-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |